ORGANOGENESIS HOLDINGS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 2.91 thousand shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-05-07
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 2.91K shares, a 85.01% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 8.75K shares, a 64.30% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 21.52K shares, a 19.86% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 103.37K shares, a 12.58% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 153.04K shares, a 20.01% decline from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 191.33K shares, a 30.85% increase from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 146.22K shares, a 33.08% decline from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 218.49K shares, a 65.30% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-03-31 | 2.91K shares 10-Q · filed 2026-05-07 | 11.66K shares derived: sum of 2 quarters · filed 2026-05-07 | 33.17K shares derived: sum of 3 quarters · filed 2026-05-07 | 136.54K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 8.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 30.27K shares derived: sum of 2 quarters · filed 2026-02-26 | 133.64K shares derived: sum of 3 quarters · filed 2026-02-26 | 153.04K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 21.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 124.89K shares derived: sum of 2 quarters · filed 2025-11-06 | 144.30K shares 10-Q · filed 2025-11-06 | 168.80K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 103.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 122.78K shares 10-Q · filed 2025-08-07 | 147.28K shares derived: sum of 3 quarters · filed 2025-08-07 | 174.13K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 19.41K shares 10-Q · filed 2025-05-08 | 43.91K shares derived: sum of 2 quarters · filed 2025-05-08 | 70.76K shares derived: sum of 3 quarters · filed 2025-05-08 | 189.00K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 24.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 51.35K shares derived: sum of 2 quarters · filed 2025-02-27 | 169.59K shares derived: sum of 3 quarters · filed 2025-02-27 | 191.33K shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 26.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 145.09K shares derived: sum of 2 quarters · filed 2024-11-12 | 166.83K shares 10-Q · filed 2024-11-12 | 230.07K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 118.24K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 139.98K shares 10-Q · filed 2024-08-08 | 203.22K shares derived: sum of 3 quarters · filed 2024-08-08 | 223.13K shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 21.74K shares 10-Q · filed 2024-05-09 | 84.98K shares derived: sum of 2 quarters · filed 2024-05-09 | 104.89K shares derived: sum of 3 quarters · filed 2024-05-09 | 138.99K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 63.24K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 83.15K shares derived: sum of 2 quarters · filed 2024-02-29 | 117.25K shares derived: sum of 3 quarters · filed 2024-02-29 | 146.22K shares 10-K · filed 2024-02-29 |
| 2023-09-30 | 19.91K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 54.01K shares derived: sum of 2 quarters · filed 2023-11-09 | 82.98K shares 10-Q · filed 2023-11-09 | 157.50K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 34.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 63.08K shares 10-Q · filed 2023-08-09 | 137.60K shares derived: sum of 3 quarters · filed 2023-08-09 | 244.83K shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 28.97K shares 10-Q · filed 2023-05-10 | 103.50K shares derived: sum of 2 quarters · filed 2023-05-10 | 210.73K shares derived: sum of 3 quarters · filed 2023-05-10 | 243.18K shares derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | 74.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 181.75K shares derived: sum of 2 quarters · filed 2023-03-01 | 214.21K shares derived: sum of 3 quarters · filed 2023-03-01 | 218.49K shares 10-K · filed 2023-03-01 |
| 2022-09-30 | 107.23K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 139.69K shares derived: sum of 2 quarters · filed 2022-11-09 | 143.97K shares 10-Q · filed 2022-11-09 | 225.86K shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 32.45K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 36.73K shares 10-Q · filed 2022-08-09 | 118.63K shares derived: sum of 3 quarters · filed 2022-08-09 | 140.29K shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 4.28K shares 10-Q · filed 2022-05-10 | 86.17K shares derived: sum of 2 quarters · filed 2022-05-10 | 107.83K shares derived: sum of 3 quarters · filed 2022-05-10 | 131.08K shares derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | 81.89K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 103.55K shares derived: sum of 2 quarters · filed 2022-03-01 | 126.80K shares derived: sum of 3 quarters · filed 2022-03-01 | 132.18K shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 21.66K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 44.90K shares derived: sum of 2 quarters · filed 2021-11-09 | 50.28K shares 10-Q · filed 2021-11-09 | 55.93K shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 23.24K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 28.62K shares 10-Q · filed 2021-08-09 | 34.27K shares derived: sum of 3 quarters · filed 2021-08-09 | 329.90K shares derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | 5.38K shares 10-Q · filed 2021-05-11 | 11.02K shares derived: sum of 2 quarters · filed 2021-05-11 | 306.65K shares derived: sum of 3 quarters · filed 2021-05-11 | 546.40K shares derived: sum of 4 quarters · filed 2021-05-11 |
| 2020-12-31 | 5.64K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 301.27K shares derived: sum of 2 quarters · filed 2021-03-16 | 541.02K shares derived: sum of 3 quarters · filed 2021-03-16 | 636.04K shares 10-K · filed 2021-03-16 |
| 2020-09-30 | 295.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 535.37K shares derived: sum of 2 quarters · filed 2020-11-09 | 630.40K shares 10-Q · filed 2020-11-09 | 653.66K shares derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | 239.74K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 334.77K shares 10-Q · filed 2020-08-10 | 358.04K shares derived: sum of 3 quarters · filed 2020-08-10 | 358.04K shares derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | 95.03K shares 10-Q · filed 2020-05-11 | 118.29K shares derived: sum of 2 quarters · filed 2020-05-11 | 118.29K shares derived: sum of 3 quarters · filed 2020-05-11 | 123.11K shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | 23.27K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | 23.27K shares derived: sum of 2 quarters · filed 2020-03-09 | 28.09K shares derived: sum of 3 quarters · filed 2020-03-09 | 34.42K shares 10-K · filed 2020-03-09 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 4.82K shares derived: sum of 2 quarters · filed 2019-11-12 | 11.15K shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 4.82K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 11.15K shares 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | 6.33K shares 10-Q · filed 2019-05-10 | |||
| 2018-12-31 | 76.66K shares 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |